Back to User profile » Dr Zhi-Qing Zhao

Papers published by Dr Zhi-Qing Zhao:

Corrigendum

Attenuation of Myocardial Fibrosis with Curcumin Is Mediated by Modulating Expression of Angiotensin II AT1/AT2 Receptors and ACE2 in Rats [Corrigendum]

Pang X, Zhang L, Bai F, Wang N, Garner RE, McKallip R, Zhao Z

Drug Design, Development and Therapy 2020, 14:2515-2516

Published Date: 26 June 2020

Original Research

Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats

Zheng RH, Bai XJ, Zhang WW, Wang J, Bai F, Yan CP, James EA, Bose HS, Wang NP, Zhao Z

Drug Design, Development and Therapy 2019, 13:2745-2757

Published Date: 6 August 2019

Original Research

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor

Zhang WW, Bai F, Wang J, Zheng RH, Yang LW, James EA, Zhao ZQ

Drug Design, Development and Therapy 2017, 11:3019-3033

Published Date: 16 October 2017

Original Research

Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats

Pang XF, Zhang LH, Bai F, Wang NP, Garner RE, McKallip RJ, Zhao ZQ

Drug Design, Development and Therapy 2015, 9:6043-6054

Published Date: 11 November 2015